Merrimack Pharmaceuticals Cuts Jobs; CEO Resigns

Merrimack Pharmaceuticals said it would slash 22% of its workforce and its chief executive resigned amid a new turnaround plan to accelerate the drugmaker ’s pipeline and shore up its finances.

Source: WSJ.com: Health - October 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news